IRFAN A GONDAL

Allopathic & Osteopathic Physicians|Internal Medicine MINEOLA, NY NPI 1306467006

General Payments — all program years on this page

$1,171.65

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 23
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,123.44 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $784.4119
Education $339.032

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $48.212
2024 $1,123.4421

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1080619484 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $72.85 02/26/2024 Education Undisputed 01/23/2026 View at CMS
1080619486 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $16.70 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080619490 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $14.26 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086931549 Novartis Pharmaceuticals Corporation $13.37 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086931551 Novartis Pharmaceuticals Corporation $17.45 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086931557 Novartis Pharmaceuticals Corporation $19.27 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086931561 Novartis Pharmaceuticals Corporation $18.84 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092287247 Boston Scientific Corporation $32.11 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092287249 Boston Scientific Corporation $105.91 04/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092287251 Boston Scientific Corporation $149.61 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092287265 Boston Scientific Corporation $14.96 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117153331 Medtronic, Inc. $161.02 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117153333 Medtronic, Inc. $31.06 08/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125401665 Abbott Laboratories $266.18 08/26/2024 Education Undisputed 01/23/2026 View at CMS
1131496272 PFIZER INC. $25.99 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131544430 PFIZER INC. $19.03 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131544555 PFIZER INC. $21.09 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131561829 PFIZER INC. $29.03 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139775119 GENZYME CORPORATION $35.00 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151066781 Phathom Pharmaceuticals, Inc. $40.78 06/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154855775 Kiniksa Pharmaceuticals International, plc $18.93 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.